Senior Financial Analyst at Abbott

Basel, Basel-Stadt, Switzerland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Bachelor’s degree in Finance, Accounting, Economics, or related field (Master’s or certifications like CPA, CMA, ACCA are a plus)
3–5 years of experience in financial planning & analysis, ideally in a multinational environment
Strong skills in SAP, Hyperion HFM, and data visualization tools (Power BI, Qlik)
Ability to translate complex data into clear, strategic recommendations
Mindset that values collaboration, problem-solving, and continuous improvement
Fluent in English; additional languages are a plus

Responsibilities

Manage the month-end closing process across global sites, ensuring accuracy and timely communication
Partner with diverse teams to consolidate financial data and provide meaningful insights that influence business outcomes
Support planning cycles, including annual plans and forecasts, and deliver reports that empower leadership decisions
Enhance reporting tools and dashboards (Power BI, Qlik) to make data accessible and actionable
Assist in resource management and project coordination, contributing to initiatives that shape the future of the organization

Skills

SAP

Hyperion HFM

Power BI

Qlik

Financial Planning

Month-end Closing

Forecasting

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free